Skip to content

The evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous leishmaniasis: A Randomized Clinical Trial

The evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous leishmaniasis: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171120004
Enrollment
Unknown
Registered
2017-11-20
Start date
2014-03-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In this randomized controlled trial of 197 cutaneous Leishmaniasis (cl) patients reported from Qom health centers in 2016&#44

Interventions

54 cases with 116 lesions received IG weekly ,58 patients with 115 lesions received the IG once a week coupled with Cryo using liquid nitrogen once every two weeks
Experimental Drug,Experimental Drug
IG weekly , the IG once a week coupled with Cryo using liquid nitrogen onc

Sponsors

Deputy of Research, Qom University of Medical Sciences,
Lead Sponsor
Deputy of Research&#44
Collaborator
Qom University of Medical Sciences&#44
Collaborator

Eligibility

Sex/Gender
All
Age
10 Years to 40 Years

Inclusion criteria

Inclusion criteria: diagnosis of leishmaniasis based on the observation leishman bodies in smears from skin lesions, the onset of the disease should be less than 4 weeks ago, completion of epidemiologic survey forms and having age 10 years or older

Exclusion criteria

Exclusion criteria: taking any drugs; antibiotics or anti-Leishmania during the last 4 weeks, lactating and pregnant mothers, having large skin lesions with a diameter of 5 cm and ultimately the patients with lesions of more than three on their bodies

Design outcomes

Primary

MeasureTime frame
At first, the lesion size and induration of lesions were recorded. first centimeter

Secondary

MeasureTime frame
After 7 and 12 weeks of treatment, lesions healing rate was monitored. After 7 and 12 weeks of treatment lesions healing

Countries

Iran

Contacts

Public ContactAbedin Saghafipour

Department of Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran

abed.saghafi@yahoo.com+982532813151

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026